Search

Your search keyword '"Galang, Romeo R"' showing total 150 results
Start Over Author "Galang, Romeo R" Search Limiters Full Text
150 results on '"Galang, Romeo R"'

1. Evaluation of cesarean delivery rates and factors associated with cesarean delivery among women enrolled in a pregnancy cohort study at two tertiary hospitals in Thailand

Author

Patamasingh Na Ayudhaya, Orada, Kittikraisak, Wanitchaya, Phadungkiatwatana, Podjanee, Hunt, Danielle Rentz, Tomyabatra, Krissada, Chotpitayasunondh, Tawee, Galang, Romeo R., Chang, Karen, Brummer, Tana, Puttanavijarn, Lunthaporn, Malek, Parker, Dawood, Fatimah S., and Mott, Joshua A.

Published
2024
Full Text
View/download PDF

2. Pregnancy, birth, infant, and early childhood neurodevelopmental outcomes among a cohort of women with symptoms of Zika virus disease during pregnancy in three surveillance sites, project Vigilancia de Embarazadas con Zika (VEZ), Colombia, 2016-2018

Author

Mercado-Reyes, Marcela, Gilboa, Suzanne M, Valencia, Diana, Daza, Marcela, Tong, Van T, Galang, Romeo R, Winfield, Christina M, Godfred-Cato, Shana, Benavides, Monica, Villanueva, Julie M, Thomas, Jennifer D, Daniels, Jonathan, Zaki, Sherif, Reagan-Steiner, Sarah, Bhatnagar, Julu, Schiffer, Jarad, Steward-Clark, Evelene, Ricaldi, Jessica N, Osorio, Johana, Sancken, Christina L, Pardo, Lissethe, Tinker, Sarah C, Anderson, Kayla N, Rico, Angelica, Burkel, Veronica K, Hojnacki, Jacob, Delahoy, Miranda J, Gonzalez, Maritza, Osorio, May B, Moore, Cynthia A, Honein, Margaret A, and Martinez, Martha Lucia Ospina

Published
2021

4. Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Author

Griffin, Isabel, Woodworth, Kate R., Galang, Romeo R., Burkel, Veronica K., Neelam, Varsha, Siebman, Samantha, Barton, Jerusha, Manning, Susan E., Aveni, Kathryn, Longcore, Nicole D., Harvey, Elizabeth M., Ngo, Van, Mbotha, Deborah, Chicchelly, Sarah, Lush, Mamie, Eckert, Valorie, Dzimira, Paula, Sokale, Ayomide, Valencia-Prado, Miguel, Azziz-Baumgartner, Eduardo, MacNeil, Adam, Gilboa, Suzanne M., and Tong, Van T.

Subjects
RNA -- Statistics -- Health aspects, Pregnant women -- Statistics -- Health aspects, Health
Abstract

Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in respiratory specimens that recurs over extended time intervals might indicate viral RNA persistence, continued viral replication, reinfection, or sample [...]

Published
2022
Full Text
View/download PDF

5. Detection of SARS-CoV-2 in Neonatal Autopsy Tissues and Placenta

Author

Reagan-Steiner, Sarah, Bhatnagar, Julu, Martines, Roosecelis B., Milligan, Nicholas S., Gisondo, Carly, Williams, Frank B., Lee, Elizabeth, Estetter, Lindsey, Bullock, Hannah, Goldsmith, Cynthia S., Fair, Pamela, Hand, Julie, Richardson, Gillian, Woodworth, Kate R., Oduyebo, Titilope, Galang, Romeo R., Phillips, Rebecca, Belyaeva, Elizaveta, Yin, Xiao-Ming, Meaney-Delman, Dana, Uyeki, Timothy M., Roberts, Drucilla J., and Zaki, Sherif R.

Subjects
Infants -- Patient outcomes, Perinatal infection -- Risk factors -- Complications and side effects -- Case studies, Premature birth -- Case studies, Health
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy is associated with severe maternal coronavirus disease (COVID-19) and preterm birth and may increase the risk for other complications of [...]

Published
2022
Full Text
View/download PDF

7. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team, Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., and Tong, Van T.

Published
2020

9. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020

Author

COVID-NET Surveillance Team, Delahoy, Miranda J., Whitaker, Michael, O’Halloran, Alissa, Chai, Shua J., Kirley, Pam Daily, Alden, Nisha, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J., Openo, Kyle P., Monroe, Maya L., Ryan, Patricia A., Fox, Kimberly, Kim, Sue, Lynfield, Ruth, Siebman, Samantha, Davis, Sarah Shrum, Sosin, Daniel M., Barney, Grant, Muse, Alison, Bennett, Nancy M., Felsen, Christina B., Billing, Laurie M., Shiltz, Jessica, Sutton, Melissa, West, Nicole, Schaffner, William, Talbot, H. Keipp, George, Andrea, Spencer, Melanie, Ellington, Sascha, Galang, Romeo R., Gilboa, Suzanne M., Tong, Van T., Piasecki, Alexandra, Brammer, Lynnette, Fry, Alicia M., Hall, Aron J., Wortham, Jonathan M., Kim, Lindsay, and Garg, Shikha

Published
2020

11. Vital Signs: Maternity Care Experiences--United States, April 2023

Author

Mohamoud, Yousra A., Cassidy, Elizabeth, Fuchs, Erika, Womack, Lindsay S., Romero, Lisa, Kipling, Lauren, Oza-Frank, Reena, Baca, Katharyn, Galang, Romeo R., Stewart, Andrea, Carrigan, Sarah, Mullen, Jennifer, Busacker, Ashley, Behm, Brittany, Hollier, Lisa M., Kroelinger, Charlan, Mueller, Trisha, Barfield, Wanda D., and Cox, Shanna

Subjects
Privacy, Right of -- Surveys -- Social aspects -- Analysis, Discrimination -- Surveys -- Social aspects -- Analysis, Mothers -- Patient outcomes, Racially mixed people -- Surveys, Privacy -- Analysis -- Surveys -- Social aspects, Privacy issue, Health
Abstract

Introduction From 2018 to 2021, the maternal death rate in the United States increased from 17.4 to 32.9 per 100,000 live births (1). Native Hawaiian and other Pacific Islander, Black, [...]

Published
2023

12. Evaluating Differences in Whole Blood, Serum, and Urine Screening Tests for Zika Virus, Puerto Rico, USA, 2016

Author

Rosinger, Asher Y., Olson, Samantha M., Ellington, Sascha R., Perez-Padilla, Janice, Simeone, Regina M., Pedati, Caitlin S., Schroeder, Betsy A., Santiago, Gilberto A., Medina, Freddy A., Munoz-Jordan, Jorge L., Adams, Laura E., Galang, Romeo R., Valencia-Prado, Miguel, Bakkour, Sonia, Colon, Candimar, Goodwin, Mary, Meaney-Delman, Dana, Read, Jennifer S., Petersen, Lyle R., Jamieson, Denise J., Deseda, Carmen C., Honein, Margaret A., Rivera-Garcia, Brenda, and Shapiro-Mendoza, Carrie K.

Subjects
Blood -- Medical examination, Urine -- Analysis, Nucleic acids -- Testing, Serodiagnosis -- Comparative analysis, Medical screening -- Comparative analysis -- Methods, Health
Abstract

Zika virus (ZIKV) infection during pregnancy can cause severe brain and eye malformations and is associated with neurodevelopmental abnormalities in affected infants (1). Currently, ZIKV testing with concurrent dengue virus [...]

Published
2021
Full Text
View/download PDF

13. Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data

Author

Kuklina, Elena V., primary, Ewing, Alexander C., additional, Satten, Glen A., additional, Callaghan, William M., additional, Goodman, David A., additional, Ferre, Cynthia D., additional, Ko, Jean Y., additional, Womack, Lindsay S., additional, Galang, Romeo R., additional, and Kroelinger, Charlan D., additional

Published
2023
Full Text
View/download PDF

15. Vital Signs : Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection — U.S. Territories and Freely Associated States, 2018

Author

Rice, Marion E., Galang, Romeo R., Roth, Nicole M., Ellington, Sascha R., Moore, Cynthia A., Valencia-Prado, Miguel, Ellis, Esther M., Tufa, Aifili John, Taulung, Livinson A., Alfred, Julia M., Pérez-Padilla, Janice, Delgado-López, Camille A., Zaki, Sherif R., Reagan-Steiner, Sarah, Bhatnagar, Julu, Nahabedian, John F., Reynolds, Megan R., Yeargin-Allsopp, Marshalyn, Viens, Laura J., Olson, Samantha M., Jones, Abbey M., Baez-Santiago, Madelyn A., Oppong-Twene, Philip, VanMaldeghem, Kelley, Simon, Elizabeth L., Moore, Jazmyn T., Polen, Kara D., Hillman, Braeanna, Ropeti, Ruta, Nieves-Ferrer, Leishla, Marcano-Huertas, Mariam, Masao, Carolee A., Anzures, Edlen J., Hansen, Ransen L., Pérez-Gonzalez, Stephany I., Espinet-Crespo, Carla P., Luciano-Román, Mildred, Shapiro-Mendoza, Carrie K., Gilboa, Suzanne M., and Honein, Margaret A.

Published
2018

16. Mpox Cases Among Cisgender Women and Pregnant Persons--United States, May 11-November 7, 2022

Author

Oakley, Lisa P., Hufstetler, Kaitlin, O'Shea, Jesse, Sharpe, J. Danielle, McArdle, Cristin, Neelam, Varsha, Roth, Nicole M., Olsen, Emily O., Wolf, Maren, Pao, Leah Zilversmit, Gold, Jeremy A.W., Davis, K. Meryl, Perella, Dana, Epstein, Shara, Lash, Maura K., Samson, Olivia, Pavlick, Jessica, Feldpausch, Amanda, Wallace, Jennifer, Nambiar, Atmaram, Ngo, Van, Halai, Umme-Aiman, Richardson, Claudia W., Fowler, Traci, Taylor, Burnestine P., Chou, Joyce, Brandon, Lindsey, Devasia, Rose, Ricketts, Erin K., Stockdale, Catherine, Roskosky, Mellisa, Ostadkar, Rachel, Vang, Yeng, Galang, Romeo R., Perkins, Kiran, Taylor, Melanie, Choi, Mary Joung, Weidle, Paul J., Dawson, Patrick, and Ellington, Sascha

Subjects
Pregnant women, Health
Abstract

Monkeypox (mpox) cases in the 2022 outbreak have primarily occurred among adult gay, bisexual, and other men who have sex with men (MSM); however, other populations have also been affected [...]

Published
2023

17. Exposures to Mpox Among Cases in Children Aged [less than or equal to] 12 Years--United States, September 25-December 31, 2022

Author

Nemechek, Kaylea, Stefanos, Ruth, Miller, Erin L., Riser, Aspen, Kebede, Bethel, Galang, Romeo R., Hufstetler, Kaitlin, Descamps, Denisse, Balenger, Adelaide, Hennessee, Ian, Neelam, Varsha, Hutchins, Helena J., Labuda, Sarah M., Davis, K. Meryl, McCormick, David W., Marx, Grace E., Kimball, Anne, Ruberto, Irene, Williamson, Thomas, Rzucidlo, Paul, Willut, Christina, Harold, Rachel E., Mangla, Anil T., English, Andrew, Brikshavana, Danucha, Blanding, Justin, Kim, Moon, Finn, Lauren E., Marutani, Amy, Lockwood, Maura, Johnson, Shannon, Ditto, Nicole, Wilton, Sara, Edmond, Tara, Stokich, Denise, Shinall, Amanda, Alravez, Bryanna, Crawley, Addie, Nambiar, Atmaram, Gateley, Emily L., Schuman, Julie, White, Stephen L., Davis, Kenneth, Milleron, Rania, Mendez, Minerva, Kawakami, Vance, Segaloff, Hannah E., Bower, William A., Ellington, Sascha R., McCollum, Andrea M., and Pao, Leah Zilversmit

Subjects
Health
Abstract

During May 17--December 31, 2022, 125 probable or confirmed U.S. monkeypox (mpox) ([dagger]) cases were reported among patients aged During September 25--December 31, 2022, 17 children aged [less than or [...]

Published
2023

18. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy — U.S. Territories, January 1, 2016–April 25, 2017

Author

Zika Pregnancy and Infant Registries Working Group, Shapiro-Mendoza, Carrie K., Rice, Marion E., Galang, Romeo R., Fulton, Anna C., VanMaldeghem, Kelley, Prado, Miguel Valencia, Ellis, Esther, Anesi, Magele Scott, Simeone, Regina M., Petersen, Emily E., Ellington, Sascha R., Jones, Abbey M., Williams, Tonya, Reagan-Steiner, Sarah, Perez-Padilla, Janice, Deseda, Carmen C., Beron, Andrew, Tufa, Aifili John, Rosinger, Asher, Roth, Nicole M., Green, Caitlin, Martin, Stacey, Lopez, Camille Delgado, deWilde, Leah, Goodwin, Mary, Pagano, H. Pamela, Mai, Cara T., Gould, Carolyn, Zaki, Sherif, Ferrer, Leishla Nieves, Davis, Michelle S., Lathrop, Eva, Polen, Kara, Cragan, Janet D., Reynolds, Megan, Newsome, Kimberly B., Huertas, Mariam Marcano, Bhatangar, Julu, Quiñones, Alma Martinez, Nahabedian, John F., Adams, Laura, Sharp, Tyler M., Hancock, W. Thane, Rasmussen, Sonja A., Moore, Cynthia A., Jamieson, Denise J., Munoz-Jordan, Jorge L., Garstang, Helentina, Kambui, Afeke, Masao, Carolee, Honein, Margaret A., and Meaney-Delman, Dana

Published
2017

19. Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox--United States, 2022

Author

Minhaj, Faisal S., Petras, Julia K., Brown, Jennifer A., Mangla, Anil T., Russo, Kelly, Willut, Christina, Lee, Michelle, Beverley, Jason, Harold, Rachel, Milroy, Lauren, Pope, Brian, Gould, Emily, Beeler, Cole, Schneider, Jack, Mostafa, Heba H., Godfred-Cato, Shana, Click, Eleanor S., Borah, Brian F., Galang, Romeo R., Cash-Goldwasser, Shama, Wong, Joshua M., McCormick, David W., Yu, Patricia A., Shelus, Victoria, Carpenter, Ann, Schatzman, Sabrina, Lowe, David, Townsend, Michael B., Davidson, Whitni, Wynn, Nhien T., Satheshkumar, Panayampalli S., O'Connor, Siobhan M., O'Laughlin, Kevin, Rao, Agam K., McCollum, Andrea M., Negron, Maria E., Hutson, Christina L., and Salzer, Johanna S.

Subjects
Human monkeypox, Health
Abstract

On September 2, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Since May 2022, approximately 20,000 cases of monkeypox have been identified in [...]

Published
2022

20. Neutralizing Antibody Responses to Messenger RNA Coronavirus Disease 2019 Vaccines Versus Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Pregnant Women and Vaccine-Induced Antibody Transfer to Infants

Author

Dawood, Fatimah S, primary, Tita, Alan, additional, Stockwell, Melissa S, additional, Newes-Adeyi, Gabriella, additional, Wielgosz, Kristina, additional, Gyamfi-Bannerman, Cynthia, additional, Battarbee, Ashley, additional, Reichle, Lawrence, additional, Thornburg, Natalie, additional, Ellington, Sascha, additional, Galang, Romeo R, additional, Vorwaller, Kelly, additional, Vargas, Celibell Y, additional, Morrill, Tyler, additional, Parks, Mickey, additional, Powers, Emily, additional, Gibson, Marie, additional, and Varner, Michael, additional

Published
2023
Full Text
View/download PDF

23. Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak — Puerto Rico, 2016

Author

Tepper, Naomi K., Goldberg, Howard I., Bernal, Manuel I. Vargas, Rivera, Brenda, Frey, Meghan T., Malave, Claritsa, Renquist, Christina M., Bracero, Nabal Jose, Dominguez, Kenneth L., Sanchez, Ramon E., Shapiro-Mendoza, Carrie K., Rodriguez, Blanca R. Cuevas, Simeone, Regina M., Pesik, Nicki T., Barfield, Wanda D., Ko, Jean Y., Galang, Romeo R., Perez-Padilla, Janice, Polen, Kara N.D., Honein, Margaret A., Rasmussen, Sonja A., and Jamieson, Denise J.

Published
2016

24. Zika Virus Infection Among U.S. Pregnant Travelers — August 2015–February 2016

Author

Meaney-Delman, Dana, Hills, Susan L., Williams, Charnetta, Galang, Romeo R., Iyengar, Preetha, Hennenfent, Andrew K., Rabe, Ingrid B., Panella, Amanda, Oduyebo, Titilope, Honein, Margaret A., Zaki, Sherif, Lindsey, Nicole, Lehman, Jennifer A., Kwit, Natalie, Bertolli, Jeanne, Ellington, Sascha, Igbinosa, Irogue, Minta, Anna A., Petersen, Emily E., Mead, Paul, Rasmussen, Sonja A., and Jamieson, Denise J.

Published
2016

27. Pregnant Women's Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018.

Author

Simeone, Regina M., House, L. Duane, Salvesen von Essen, Beatriz, Kortsmit, Katherine, Hernandez Virella, Wanda, Vargas Bernal, Manuel I., Galang, Romeo R., D'Angelo, Denise V., Shapiro-Mendoza, Carrie K., and Ellington, Sascha R.

Subjects
POSTPARTUM depression, CONFIDENCE intervals, PREGNANT women, EXPERIENCE, RISK assessment, NATURAL disasters, CHILD health services, DESCRIPTIVE statistics, DISEASE prevalence, PRENATAL care
Abstract

Objective: Exposure to natural disasters during and after pregnancy may increase adverse mental health outcomes. Hurricanes Irma and Maria struck Puerto Rico in September 2017. Our objectives were to understand hurricane-related experiences, maternal health concerns, and the impact of hurricane experiences on postpartum depressive symptoms (PDS). Methods: We used data from the 2018 Pregnancy Risk Assessment Monitoring System to describe differences in maternal hurricane experiences among women who were pregnant during and after the 2017 hurricanes. We assessed maternal concerns and PDS. We estimated adjusted prevalence ratios (aPRs) and 95% CIs for the associations between hurricane experiences and PDS. Results: The most frequently reported hurricane experiences were losing power for ≥1 week (97%) and feeling unsafe due to lack of order/security (70%). Almost 30% of women who were pregnant during the hurricanes reported missing prenatal care. PDS were reported by 13% of women. Most hurricane experiences were associated with an increased prevalence of PDS. Feeling unsafe (aPR = 2.4; 95% CI, 1.2-4.9) and having difficulty getting food (aPR = 2.1; 95% CI, 1.1-4.1) had the strongest associations. Conclusions: Most women who were pregnant during or after hurricanes Irma and Maria struck Puerto Rico reported negative hurricane experiences, and most experiences were associated with an increased prevalence of PDS. Understanding the experiences of pregnant women during and after disasters and identifying risks for adverse mental health outcomes after pregnancy are important to inform emergency preparedness and prenatal and postpartum care. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

28. Severe acute respiratory syndrome coronavirus 2 seroprevalence and longitudinal antibody response following natural infection in pregnancy: A prospective cohort study

Author

Drake, Alison L, primary, Escudero, Jaclyn N, additional, Aurelio, Morgan C, additional, Wetzler, Erica A, additional, Ellington, Sascha R, additional, Zapata, Lauren B, additional, Galang, Romeo R, additional, Snead, Margaret C, additional, Yamamoto, Krissy, additional, Salerno, Carol C, additional, Richardson, Barbra A, additional, Greninger, Alexander L, additional, Kachikis, Alisa B, additional, Englund, Janet A, additional, and LaCourse, Sylvia M, additional

Published
2023
Full Text
View/download PDF

29. sj-docx-1-phr-10.1177_00333549221142571 – Supplemental material for Pregnant Women’s Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018

Author

Simeone, Regina M., House, L. Duane, Salvesen von Essen, Beatriz, Kortsmit, Katherine, Hernandez Virella, Wanda, Vargas Bernal, Manuel I., Galang, Romeo R., D’Angelo, Denise V., Shapiro-Mendoza, Carrie K., and Ellington, Sascha R.

Subjects
111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences
Abstract

Supplemental material, sj-docx-1-phr-10.1177_00333549221142571 for Pregnant Women’s Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018 by Regina M. Simeone, L. Duane House, Beatriz Salvesen von Essen, Katherine Kortsmit, Wanda Hernandez Virella, Manuel I. Vargas Bernal, Romeo R. Galang, Denise V. D’Angelo, Carrie K. Shapiro-Mendoza and Sascha R. Ellington in Public Health Reports

Published
2023
Full Text
View/download PDF

30. sj-pdf-2-phr-10.1177_00333549221142571 – Supplemental material for Pregnant Women’s Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018

Author

Simeone, Regina M., House, L. Duane, Salvesen von Essen, Beatriz, Kortsmit, Katherine, Hernandez Virella, Wanda, Vargas Bernal, Manuel I., Galang, Romeo R., D’Angelo, Denise V., Shapiro-Mendoza, Carrie K., and Ellington, Sascha R.

Subjects
111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences
Abstract

Supplemental material, sj-pdf-2-phr-10.1177_00333549221142571 for Pregnant Women’s Experiences During and After Hurricanes Irma and Maria, Pregnancy Risk Assessment Monitoring System, Puerto Rico, 2018 by Regina M. Simeone, L. Duane House, Beatriz Salvesen von Essen, Katherine Kortsmit, Wanda Hernandez Virella, Manuel I. Vargas Bernal, Romeo R. Galang, Denise V. D’Angelo, Carrie K. Shapiro-Mendoza and Sascha R. Ellington in Public Health Reports

Published
2023
Full Text
View/download PDF

31. Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015

Author

Conrad, Caitlin, Bradley, Heather M., Broz, Dita, Buddha, Swamy, Chapman, Erika L., Galang, Romeo R., Hillman, Daniel, Hon, John, Hoover, Karen W., Patel, Monita R., Perez, Andrea, Peters, Philip J., Pontones, Pam, Roseberry, Jeremy C., Sandoval, Michelle, Shields, Jessica, Walthall, Jennifer, Waterhouse, Dorothy, Weidle, Paul J., Wu, Hsiu, and Duwve, Joan M.

Published
2015

34. Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy — SET-NET, 16 Jurisdictions, March 29–October 14, 2020

Author

Woodworth, Kate R., Olsen, Emily O’Malley, Neelam, Varsha, Lewis, Elizabeth L., Galang, Romeo R., Oduyebo, Titilope, Aveni, Kathryn, Yazdy, Mahsa M., Harvey, Elizabeth, Longcore, Nicole D., Barton, Jerusha, Fussman, Chris, Siebman, Samantha, Lush, Mamie, Patrick, Paul H., Halai, Umme-Aiman, Valencia-Prado, Miguel, Orkis, Lauren, Sowunmi, Similoluwa, Schlosser, Levi, Khuwaja, Salma, Read, Jennifer S., Hall, Aron J., Meaney-Delman, Dana, Ellington, Sascha R., Gilboa, Suzanne M., Tong, Van T., Delaney, Augustina, Hsia, Jason, King, Kellianne, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Sancken, Christina, Sims, John, Smoots, Ashley, Snead, Margaret, Strid, Penelope, Yowe-Conley, Tineka, Zambrano, Laura, Zapata, Lauren, Manning, Susan, Burkel, Veronica, Akosa, Amanda, Bennett, Carolyne, Griffin, Isabel, Nahabedian, John, Newton, Suzanne, Roth, Nicole M., Shinde, Neha, Whitehouse, Erin, Chang, Daniel, Fox, Charise, Mohamoud, Yousra, and Whitehill, Florence

Subjects
Health (social science), Epidemiology, Health, Toxicology and Mutagenesis, Abortion, 01 natural sciences, 0302 clinical medicine, COVID-19 Testing, Health Information Management, Pregnancy, Infection control, 030212 general & internal medicine, Full Report, Young adult, Pregnancy Complications, Infectious, education.field_of_study, Obstetrics, Pregnancy Outcome, Gestational age, General Medicine, Premature birth, Premature Birth, Female, Coronavirus Infections, Adult, medicine.medical_specialty, Population, Pneumonia, Viral, Risk Assessment, 03 medical and health sciences, Betacoronavirus, Young Adult, medicine, Humans, 0101 mathematics, education, Pandemics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, Public health, 010102 general mathematics, Infant, Newborn, COVID-19, medicine.disease, Infectious Disease Transmission, Vertical, United States, Abortion, Spontaneous, business, Laboratories
Abstract

Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness and might be at risk for preterm birth (1-3). The full impact of infection with SARS-CoV-2, the virus that causes COVID-19, in pregnancy is unknown. Public health jurisdictions report information, including pregnancy status, on confirmed and probable COVID-19 cases to CDC through the National Notifiable Diseases Surveillance System.* Through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), 16 jurisdictions collected supplementary information on pregnancy and infant outcomes among 5,252 women with laboratory-confirmed SARS-CoV-2 infection reported during March 29-October 14, 2020. Among 3,912 live births with known gestational age, 12.9% were preterm (

Published
2020

35. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status — United States, January 22–October 3, 2020

Author

Zambrano, Laura D., Ellington, Sascha, Strid, Penelope, Galang, Romeo R., Oduyebo, Titilope, Tong, Van T., Woodworth, Kate R., Nahabedian, John F., Azziz-Baumgartner, Eduardo, Gilboa, Suzanne M., Meaney-Delman, Dana, Akosa, Amanda, Bennett, Carolyne, Burkel, Veronica, Chang, Daniel, Delaney, Augustina, Fox, Charise, Griffin, Isabel, Hsia, Jason, Krause, Katie, Lewis, Elizabeth, Manning, Susan, Mohamoud, Yousra, Newton, Suzanne, Neelam, Varsha, Olsen, Emily O’Malley, Perez, Mirna, Reynolds, Megan, Riser, Aspen, Rivera, Maria, Roth, Nicole M., Sancken, Christina, Shinde, Neha, Smoots, Ashley, Snead, Margaret, Wallace, Bailey, Whitehill, Florence, Whitehouse, Erin, and Zapata, Lauren

Subjects
Adult, medicine.medical_specialty, Health (social science), Adolescent, Epidemiology, Health, Toxicology and Mutagenesis, medicine.medical_treatment, Pneumonia, Viral, Prenatal care, 01 natural sciences, Risk Assessment, Severity of Illness Index, law.invention, 03 medical and health sciences, Betacoronavirus, Young Adult, 0302 clinical medicine, COVID-19 Testing, Health Information Management, law, Pregnancy, Severity of illness, Extracorporeal membrane oxygenation, medicine, Humans, 030212 general & internal medicine, Full Report, 0101 mathematics, Young adult, Pregnancy Complications, Infectious, Pandemics, Obstetrics, business.industry, Clinical Laboratory Techniques, SARS-CoV-2, 010102 general mathematics, COVID-19, General Medicine, medicine.disease, Intensive care unit, United States, Relative risk, Female, Symptom Assessment, Risk assessment, business, Coronavirus Infections, Laboratories
Abstract

Studies suggest that pregnant women might be at increased risk for severe illness associated with coronavirus disease 2019 (COVID-19) (1,2). This report provides updated information about symptomatic women of reproductive age (15-44 years) with laboratory-confirmed infection with SARS-CoV-2, the virus that causes COVID-19. During January 22-October 3, CDC received reports through national COVID-19 case surveillance or through the National Notifiable Diseases Surveillance System (NNDSS) of 1,300,938 women aged 15-44 years with laboratory results indicative of acute infection with SARS-CoV-2. Data on pregnancy status were available for 461,825 (35.5%) women with laboratory-confirmed infection, 409,462 (88.7%) of whom were symptomatic. Among symptomatic women, 23,434 (5.7%) were reported to be pregnant. After adjusting for age, race/ethnicity, and underlying medical conditions, pregnant women were significantly more likely than were nonpregnant women to be admitted to an intensive care unit (ICU) (10.5 versus 3.9 per 1,000 cases; adjusted risk ratio [aRR] = 3.0; 95% confidence interval [CI] = 2.6-3.4), receive invasive ventilation (2.9 versus 1.1 per 1,000 cases; aRR = 2.9; 95% CI = 2.2-3.8), receive extracorporeal membrane oxygenation (ECMO) (0.7 versus 0.3 per 1,000 cases; aRR = 2.4; 95% CI = 1.5-4.0), and die (1.5 versus 1.2 per 1,000 cases; aRR = 1.7; 95% CI = 1.2-2.4). Stratifying these analyses by age and race/ethnicity highlighted disparities in risk by subgroup. Although the absolute risks for severe outcomes for women were low, pregnant women were at increased risk for severe COVID-19-associated illness. To reduce the risk for severe illness and death from COVID-19, pregnant women should be counseled about the importance of seeking prompt medical care if they have symptoms and measures to prevent SARS-CoV-2 infection should be strongly emphasized for pregnant women and their families during all medical encounters, including prenatal care visits. Understanding COVID-19-associated risks among pregnant women is important for prevention counseling and clinical care and treatment.

Published
2020

37. sj-pptx-1-phr-10.1177_00333549221099244 – Supplemental material for COVID-19 Vaccination and Intent Among Pregnant Women, United States, April 2021

Author

Razzaghi, Hilda, Kahn, Katherine E., Masalovich, Svetlana, Black, Carla L., Nguyen, Kimberly H., Barfield, Wanda D., Galang, Romeo R., and Singleton, James A.

Subjects
111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences
Abstract

Supplemental material, sj-pptx-1-phr-10.1177_00333549221099244 for COVID-19 Vaccination and Intent Among Pregnant Women, United States, April 2021 by Hilda Razzaghi, Katherine E. Kahn, Svetlana Masalovich, Carla L. Black, Kimberly H. Nguyen, Wanda D. Barfield, Romeo R. Galang and James A. Singleton in Public Health Reports

Published
2022
Full Text
View/download PDF

39. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19--COVID-NET, 13 States, March 1-August 22, 2020

Author

Delahoy, Miranda J., Whitaker, Michael, O'Halloran, Alissa, Chai, Shua J., Kirley, Pam Daily, Alden, Nisha, Kawasaki, Breanna, Meek, James, Yousey-Hindes, Kimberly, Anderson, Evan J., Openo, Kyle P., Monroe, Maya L., Ryan, Patricia A., Fox, Kimberly, Kim, Sue, Lynfield, Ruth, Siebman, Samantha, Davis, Sarah Shrum, Sosin, Daniel M., Barney, Grant, Muse, Alison, Bennett, Nancy M., Felsen, Christina B., Billing, Laurie M., Shiltz, Jessica, Sutton, Melissa, West, Nicole, Schaffner, William, Talbot, H. Keipp, George, Andrea, Spencer, Melanie, Ellington, Sascha, Galang, Romeo R., Gilboa, Suzanne M., Tong, Van T., Piasecki, Alexandra, Brammer, Lynnette, Fry, Alicia M., Hall, Aron J., Wortham, Jonathan M., Kim, Lindsay, and Garg, Shikha

Subjects
Pregnant women -- Health aspects, COVID-19 -- Health aspects, Health
Abstract

On September 16, 2020, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). Pregnant women might be at increased risk for severe coronavirus disease 2019 [...]

Published
2020

41. Exposures to Mpox Among Cases in Children Aged =12 Years -- United States, September 25- December 31, 2022.

Author

Nemechek, Kaylea, Stefanos, Ruth, Miller, Erin L., Riser, Aspen, Kebede, Bethel, Galang, Romeo R., Hufstetler, Kaitlin, Descamps, Denisse, Balenger, Adelaide, Hennessee, Ian, Neelam, Varsha, Hutchins, Helena J., Labuda, Sarah M., Davis, K. Meryl, McCormick, David W., Marx, Grace E., Kimball, Anne, Ruberto, Irene, Williamson, Thomas, and Rzucidlo, Paul

Subjects
PREVENTIVE pediatrics, MONKEYPOX virus, DISEASE prevalence, INFECTIOUS disease transmission
Abstract

The article focuses on the epidemiology of monkeypox in children aged around 12 years during the 2022 outbreak in the United States. Highlighting the transmission routes, the occurrence of cases in neonates and the importance of implementing immediate protective measures for household contacts to prevent transmission to children, emphasizing the need for early diagnosis, infection control and timely implementation of prevention strategies to reduce monkeypox transmission.

Published
2023
Full Text
View/download PDF

42. Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection – Surveillance for Emerging Threats to Mothers and Babies Network, 22 state, local, and territorial health departments, March 29, 2020 -March 5, 2021

Author

Galang, Romeo R, Newton, Suzanne M, Woodworth, Kate R, Griffin, Isabel, Oduyebo, Titilope, Sancken, Christina L, Olsen, Emily O'Malley, Aveni, Kathryn, Wingate, Heather, Shephard, Hanna, Fussman, Chris, Alaali, Zahra S, Silcox, Kristin, Siebman, Samantha, Halai, Umme-Aiman, Lopez, Camille Delgado, Lush, Mamie, Sokale, Ayomide, Barton, Jerusha, Chaudhary, Ifrah, Patrick, Paul H, Schlosser, Levi, Reynolds, Bethany, Gaarenstroom, Nicole, Chicchelly, Sarah, Read, Jennifer S, de Wilde, Leah, Mbotha, Deborah, Azziz-Baumgartner, Eduardo, Hall, Aron J, Tong, Van T, Ellington, Sascha, and Gilboa, Suzanne M

Subjects
Adult, SARS-CoV-2, COVID-19, Mothers, macromolecular substances, AcademicSubjects/MED00290, illness severity, Pregnancy, Risk Factors, Humans, Supplement Article, Female, Pregnant Women, Pregnancy Complications, Infectious, Aged
Abstract

Background Pregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with SARS-CoV-2 infection. Methods Pregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during March 29, 2020–March 5, 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics. Results Among 7,950 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 25 years and older, healthcare occupation, pre-pregnancy obesity, chronic lung disease, chronic hypertension, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions. Conclusions Older age and having underlying medical conditions were associated with increased risk of moderate-to-severe or critical COVID-19 illness among pregnant women. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and inform targeted public health messaging.

Published
2021

43. Severe Coronavirus Infections in Pregnancy

Author

Galang, Romeo R., Chang, Karen, Strid, Penelope, Snead, Margaret Christine, Woodworth, Kate R., House, Lawrence D., Perez, Mirna, Barfield, Wanda D., Meaney-Delman, Dana, Jamieson, Denise J., Shapiro-Mendoza, Carrie K., and Ellington, Sascha R.

Subjects
Obstetrics and Gynaecology
Published
2020
Full Text
View/download PDF

44. Pregnancy, Birth, Infant, and Early Childhood Neurodevelopmental Outcomes among a Cohort ofWomen with Symptoms of Zika Virus Disease during Pregnancy in Three Surveillance Sites, Project Vigilancia de Embarazadas con Zika (VEZ), Colombia, 2016–2018.

Author

Mercado-Reyes, Marcela, Gilboa, Suzanne M., Valencia, Diana, Daza, Marcela, Tong, Van T., Galang, Romeo R., Winfield, Christina M., Godfred-Cato, Shana, Benavides, Mónica, Villanueva, Julie M., Thomas, Jennifer D., Daniels, Jonathan, Zaki, Sherif, Reagan-Steiner, Sarah, Bhatnagar, Julu, Schiffer, Jarad, Steward-Clark, Evelene, Ricaldi, Jessica N., Osorio, Johana, and Sancken, Christina L.

Published
2021
Full Text
View/download PDF

45. Vital Signs:Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection — U.S. Territories and Freely Associated States, 2018

Author

Rice, Marion E., primary, Galang, Romeo R., additional, Roth, Nicole M., additional, Ellington, Sascha R., additional, Moore, Cynthia A., additional, Valencia-Prado, Miguel, additional, Ellis, Esther M., additional, Tufa, Aifili John, additional, Taulung, Livinson A., additional, Alfred, Julia M., additional, Pérez-Padilla, Janice, additional, Delgado-López, Camille A., additional, Zaki, Sherif R., additional, Reagan-Steiner, Sarah, additional, Bhatnagar, Julu, additional, Nahabedian, John F., additional, Reynolds, Megan R., additional, Yeargin-Allsopp, Marshalyn, additional, Viens, Laura J., additional, Olson, Samantha M., additional, Jones, Abbey M., additional, Baez-Santiago, Madelyn A., additional, Oppong-Twene, Philip, additional, VanMaldeghem, Kelley, additional, Simon, Elizabeth L., additional, Moore, Jazmyn T., additional, Polen, Kara D., additional, Hillman, Braeanna, additional, Ropeti, Ruta, additional, Nieves-Ferrer, Leishla, additional, Marcano-Huertas, Mariam, additional, Masao, Carolee A., additional, Anzures, Edlen J., additional, Hansen, Ransen L., additional, Pérez-Gonzalez, Stephany I., additional, Espinet-Crespo, Carla P., additional, Luciano-Román, Mildred, additional, Shapiro-Mendoza, Carrie K., additional, Gilboa, Suzanne M., additional, and Honein, Margaret A., additional

Published
2018
Full Text
View/download PDF

46. Cluster of HIV infections attributed to unsafe injection practices--Cambodia, December 1, 2014-February 28, 2015

Author

Vun, Mean Chhi, Galang, Romeo R., Fujita, Masami, Killam, William, Gokhale, Runa, Pitman, John, Selenic, Dejana, Mam, Sovatha, Mom, Chandara, Fontenille, Didier, Rouet, Francois, and Vonthanak, Saphonn

Subjects
HIV (Viruses) -- Health aspects, AIDS (Disease) -- Health aspects, Health
Abstract

In December 2014, local health authorities in Battambang province in northwest Cambodia reported 30 cases of human immunodeficiency virus (HIV) infection in a rural commune (district subdivision) where only four [...]

Published
2016

47. Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.

Author

Shapiro-Mendoza, Carrie K., Rice, Marion E., Galang, Romeo R., Fulton, Anna C., VanMaldeghem, Kelley, Prado, Miguel Valencia, Ellis, Esther, Anesi, Magele Scott, Simeone, Regina M., Petersen, Emily E., Ellington, Sascha R., Jones, Abbey M., Williams, Tonya, Reagan-Steiner, Sarah, Perez-Padilla, Janice, Deseda, Carmen C., Beron, Andrew, Tufa, Aifili John, Rosinger, Asher, and Roth, Nicole M.

Subjects
ZIKA virus infections, ZIKA virus, PREGNANT women, MICROCEPHALY, VIRAL transmission
Abstract

Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for Zika virus infection, which can lead to severe fetal and infant brain abnormalities and microcephaly (1). In February 2016, CDC recommended 1) routine testing for Zika virus infection of asymptomatic pregnant women living in areas with ongoing local Zika virus transmission at the first prenatal care visit, 2) retesting during the second trimester for women who initially test negative, and 3) testing of pregnant women with signs or symptoms consistent with Zika virus disease (e.g., fever, rash, arthralgia, or conjunctivitis) at any time during pregnancy (2). To collect information about pregnant women with laboratory evidence of recent possible Zika virus infection* and outcomes in their fetuses and infants, CDC established pregnancy and infant registries (3). During January 1, 2016-April 25, 2017, U.S. territories† with local transmission of Zika virus reported 2,549 completed pregnancies§ (live births and pregnancy losses at any gestational age) with laboratory evidence of recent possible Zika virus infection; 5% of fetuses or infants resulting from these pregnancies had birth defects potentially associated with Zika virus infection¶ (4,5). Among completed pregnancies with positive nucleic acid tests confirming Zika infection identified in the first, second, and third trimesters, the percentage of fetuses or infants with possible Zika-associated birth defects was 8%, 5%, and 4%, respectively. Among liveborn infants, 59% had Zika laboratory testing results reported to the pregnancy and infant registries. Identification and follow-up of infants born to women with laboratory evidence of recent possible Zika virus infection during pregnancy permits timely and appropriate clinical intervention services (6). [ABSTRACT FROM AUTHOR]

Published
2017
Full Text
View/download PDF

48. Possible Zika Virus Infection Among Pregnant Women - United States and Territories, May 2016.

Author

Simeone, Regina M., Shapiro-Mendoza, Carrie K., Meaney-Delman, Dana, Petersen, Emily E., Galang, Romeo R., Oduyebo, Titilope, Rivera-Garcia, Brenda, Valencia-Prado, Miguel, Newsome, Kimberly B., Perez-Padilla, Janice, Williams, Tonya R., Biggerstaff, Matthew, Jamieson, Denise J., Honein, Margaret A., Pérez-Padilla, Janice, and Zika and Pregnancy Working Group

Subjects
ZIKA virus infections, ZIKA virus, GUIDELINES, MATERNAL health, MICROCEPHALY, PUBLIC health surveillance, DISEASE risk factors
Abstract

Zika virus is a cause of microcephaly and brain abnormalities (1), and it is the first known mosquito-borne infection to cause congenital anomalies in humans. The establishment of a comprehensive surveillance system to monitor pregnant women with Zika virus infection will provide data to further elucidate the full range of potential outcomes for fetuses and infants of mothers with asymptomatic and symptomatic Zika virus infection during pregnancy. In February 2016, Zika virus disease and congenital Zika virus infections became nationally notifiable conditions in the United States (2). Cases in pregnant women with laboratory evidence of Zika virus infection who have either 1) symptomatic infection or 2) asymptomatic infection with diagnosed complications of pregnancy can be reported as cases of Zika virus disease to ArboNET* (2), CDC's national arboviral diseases surveillance system. Under existing interim guidelines from the Council for State and Territorial Epidemiologists (CSTE), asymptomatic Zika virus infections in pregnant women who do not have known pregnancy complications are not reportable. ArboNET does not currently include pregnancy surveillance information (e.g., gestational age or pregnancy exposures) or pregnancy outcomes. To understand the full impact of infection on the fetus and neonate, other systems are needed for reporting and active monitoring of pregnant women with laboratory evidence of possible Zika virus infection during pregnancy. Thus, in collaboration with state, local, tribal, and territorial health departments, CDC established two surveillance systems to monitor pregnancies and congenital outcomes among women with laboratory evidence of Zika virus infection(†) in the United States and territories: 1) the U.S. Zika Pregnancy Registry (USZPR),(§) which monitors pregnant women residing in U.S. states and all U.S. territories except Puerto Rico, and 2) the Zika Active Pregnancy Surveillance System (ZAPSS), which monitors pregnant women residing in Puerto Rico. As of May 12, 2016, the surveillance systems were monitoring 157 and 122 pregnant women with laboratory evidence of possible Zika virus infection from participating U.S. states and territories, respectively. Tracking and monitoring clinical presentation of Zika virus infection, all prenatal testing, and adverse consequences of Zika virus infection during pregnancy are critical to better characterize the risk for congenital infection, the performance of prenatal diagnostic testing, and the spectrum of adverse congenital outcomes. These data will improve clinical guidance, inform counseling messages for pregnant women, and facilitate planning for clinical and public health services for affected families. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

49. Cluster of HIV Infections Attributed to Unsafe Injection Practices — Cambodia, December 1, 2014-February 28, 2015.

Author

Chhi Vun, Mean, Galang, Romeo R., Fujita, Masami, Killam, William, Gokhale, Runa, Pitman, John, Selenic, Dejana, Mam, Sovatha, Mom, Chandara, Fontenille, Didier, Rouet, Francois, and Vonthanak, Saphonn

Subjects
*HIV prevention, *MEDICAL care of HIV-positive persons, *HIV infection transmission, *NEEDLE exchange programs, *ENZYME-linked immunosorbent assay, *SEX education
Abstract

The article presents the results of a clinical investigation by Roka Cluster Investigation team, concerning the risk factors, confirmed cases and recommended control strategies of HIV infections in Battambang province, Cambodia. The clinical study examines the risk factors associated with HIV infection, using an enzyme immunoassay method. The article also discusses the government's prevention strategies against HIV infections and promotion of safe injection practices.

Published
2016

50. Vital Signs: Maternity Care Experiences - United States, April 2023.

Author

Mohamoud YA, Cassidy E, Fuchs E, Womack LS, Romero L, Kipling L, Oza-Frank R, Baca K, Galang RR, Stewart A, Carrigan S, Mullen J, Busacker A, Behm B, Hollier LM, Kroelinger C, Mueller T, Barfield WD, and Cox S

Subjects
Female, Humans, Pregnancy, Ethnicity, Hispanic or Latino, Vital Signs, Black or African American, United States, Maternal Health Services
Abstract

Introduction: Maternal deaths increased in the United States during 2018-2021, with documented racial disparities. Respectful maternity care is a component of quality care that includes preventing harm and mistreatment, engaging in effective communication, and providing care equitably. Improving respectful maternity care can be part of multilevel strategies to reduce pregnancy-related deaths., Methods: CDC analyzed data from the PN View Moms survey administered during April 24-30, 2023, to examine the following components of respectful care: 1) experiences of mistreatment (e.g., violations of physical privacy, ignoring requests for help, or verbal abuse), 2) discrimination (e.g., because of race, ethnicity or skin color; age; or weight), and 3) reasons for holding back from communicating questions or concerns during maternity (pregnancy or delivery) care., Results: Among U.S. mothers with children aged <18 years, 20% reported mistreatment while receiving maternity care for their youngest child. Approximately 30% of Black, Hispanic, and multiracial respondents and approximately 30% of respondents with public insurance or no insurance reported mistreatment. Discrimination during the delivery of maternity care was reported by 29% of respondents. Approximately 40% of Black, Hispanic, and multiracial respondents reported discrimination, and approximately 45% percent of all respondents reported holding back from asking questions or discussing concerns with their provider., Conclusions and Implications for Public Health Practice: Approximately one in five women reported mistreatment during maternity care. Implementing quality improvement initiatives and provider training to encourage a culture of respectful maternity care, encouraging patients to ask questions and share concerns, and working with communities are strategies to improve respectful maternity care., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results